427 related articles for article (PubMed ID: 30431060)
1. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
3. Silencing FYVE, RhoGEF, and PH domain containing 1 (FGD1) suppresses melanoma progression by inhibiting PI3K/AKT signaling pathway.
Niu Z; Li Y; Xu Y; Jiang W; Tao R; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(2):12193-12205. PubMed ID: 34783295
[TBL] [Abstract][Full Text] [Related]
4. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
5. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
6. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
7. FARP1 Facilitates Cell Proliferation Through Modulating MAPK Signaling Pathway in Cutaneous Melanoma.
Chen ZH; Wang LH
Am J Dermatopathol; 2019 Dec; 41(12):908-913. PubMed ID: 31021836
[TBL] [Abstract][Full Text] [Related]
8. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SLC25A15 is involved in the proliferation of cutaneous melanoma and leads to poor prognosis.
Ji SM
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():74-80. PubMed ID: 30403179
[TBL] [Abstract][Full Text] [Related]
10. NAV2 facilitates invasion of cutaneous melanoma cells by targeting SNAI2 through the GSK-3β/β-catenin pathway.
Hu W; Li X; Cheng R; Ke J; Liu Y; Ma M; Cao Y; Liu D
Arch Dermatol Res; 2019 Jul; 311(5):399-410. PubMed ID: 30997569
[TBL] [Abstract][Full Text] [Related]
11. FOXD2-AS1 correlates with the malignant status and regulates cell proliferation, migration, and invasion in cutaneous melanoma.
Ren W; Zhu Z; Wu L
J Cell Biochem; 2019 Apr; 120(4):5417-5423. PubMed ID: 30426532
[TBL] [Abstract][Full Text] [Related]
12. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-603 Promotes Progression of Cutaneous Melanoma by Regulating TBX5.
Dong X; Wang Y; Qu Y; Liu J; Feng X; Xu X
Comput Math Methods Med; 2021; 2021():1888501. PubMed ID: 35003317
[TBL] [Abstract][Full Text] [Related]
14. Multiple pro-tumorigenic functions of the human minor Histocompatibility Antigen-1 (HA-1) in melanoma progression.
Xu P; Ma J; Ma J; Zhang W; Guo S; Jian Z; Liu L; Wang G; Gao T; Zhu G; Li C
J Dermatol Sci; 2017 Nov; 88(2):216-224. PubMed ID: 28939173
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of microRNA‑21 inhibits the growth and metastasis of melanoma cells by targeting MKK3.
Zhou M; Yu X; Jing Z; Wu W; Lu C
Mol Med Rep; 2019 Aug; 20(2):1797-1807. PubMed ID: 31257538
[TBL] [Abstract][Full Text] [Related]
16. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
Wang J; Li L; Liu S; Zhao Y; Wang L; Du G
Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251
[TBL] [Abstract][Full Text] [Related]
17. Regulators CDCA8 as potential targets and biomarkers for the prognosis of human skin cutaneous melanoma.
Guo R; Ying J; Jia L; Zhuang N; Jiang H; Xiong J
J Cosmet Dermatol; 2022 Nov; 21(11):6034-6048. PubMed ID: 35575979
[TBL] [Abstract][Full Text] [Related]
18. Nucleosome assembly protein 1-like 4, a new therapeutic target for proliferation and invasion of melanoma cells.
Mizuhashi S; Fukushima S; Ishibashi T; Kuriyama H; Kimura T; Kanemaru H; Kajihara I; Makino K; Miyashita A; Aoi J; Kita K; Ihn H
J Dermatol Sci; 2021 Apr; 102(1):16-24. PubMed ID: 33583643
[TBL] [Abstract][Full Text] [Related]
19. Karyopherin α 2 promotes proliferation, migration and invasion through activating NF-κB/p65 signaling pathways in melanoma cells.
Yang F; Li S; Cheng Y; Li J; Han X
Life Sci; 2020 Jul; 252():117611. PubMed ID: 32243925
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FENDRR inhibits migration and invasion of cutaneous malignant melanoma cells.
Chen XE; Chen P; Chen S; Lu J; Ma T; Shi G; Sheng L
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32134466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]